News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>BOCI: JD.com (JD.US) 4Q25 Results in Line; Rating Buy
JD-SW (09618.HK)'s 4Q25 results were in line with expectations, BOCI released a research report saying. Total revenue grew 2% YoY, with merchandise revenue declining 3% YoY and...
Reset
Send
The window will close in 5 seconds
<Research>BOCI: JD.com (JD.US) 4Q25 Results in Line; Rating Buy
Close
Recommend
20
Positive
24
Negative
10
 
 

JD-SW (09618.HK)  -1.000 (-0.886%)    Short selling $333.77M; Ratio 174.780%   's 4Q25 results were in line with expectations, BOCI released a research report saying. Total revenue grew 2% YoY, with merchandise revenue declining 3% YoY and service revenue rising 20% YoY.

The broker believed that the Company will steadfastly enhance its core capabilities in 2026, focusing more on expanding three new businesses efficiently and accelerating AI empowerment.

Related News Citi Bullish on JD.com (JD.US) Core Retail Profitability, Shareholder Returns; TP USD35
Of which, UE optimization driven by progressive commercialization and refined operations, along with cross-selling of core JD Retail, will be key priorities for its food delivery business in 2026.

Therefore, the broker kept its target price for JD.com (JD.US)      's US stock at US$34 and rating at Buy.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.